S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|ImmunoGen, Inc. Announces Conference Call to Discuss Its First Quarter Fiscal Year 2015 Financial Results|
|ImmunoGen, Inc. Announces Morgan Stanley Global Healthcare Conference Webcast|
|ImmunoGen, Inc. Hires Sandra E. Poole as Senior Vice President of Technical Operations|
|ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results|
|Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC|
|Initiation of Multiple Ascending Dose Phase 1 Study of PRX002 in Patients With Parkinson's Disease|
|Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™|
|Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine|
|Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data|
|Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine|
Click above to view more mutual fund data and stats for imgn - Immunogen Inc.